1. Home
  2. BDTX vs SMJF Comparison

BDTX vs SMJF Comparison

Compare BDTX & SMJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$1.68

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Logo SMJ International Holdings Inc. Class A Ordinary Shares

SMJF

SMJ International Holdings Inc. Class A Ordinary Shares

HOLD

Current Price

$5.64

Market Cap

145.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDTX
SMJF
Founded
2014
1988
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.9M
145.5M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
BDTX
SMJF
Price
$1.68
$5.64
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$9.67
N/A
AVG Volume (30 Days)
929.0K
934.2K
Earning Date
05-08-2026
09-04-2026
Dividend Yield
N/A
N/A
EPS Growth
130.71
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$68.08
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$0.82
52 Week High
$4.94
$5.80

Technical Indicators

Market Signals
Indicator
BDTX
SMJF
Relative Strength Index (RSI) 37.69 63.22
Support Level $1.60 $4.96
Resistance Level $1.90 $5.80
Average True Range (ATR) 0.09 0.17
MACD -0.01 0.01
Stochastic Oscillator 7.81 86.15

Price Performance

Historical Comparison
BDTX
SMJF

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

About SMJF SMJ International Holdings Inc. Class A Ordinary Shares

SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.

Share on Social Networks: